关注
John H. Griffin
John H. Griffin
Professor of Molecular & Experimental Medicine
在 scripps.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Deficiency of protein C in congenital thrombotic disease.
JH Griffin, B Evatt, TS Zimmerman, AJ Kleiss, C Wideman
The Journal of clinical investigation 68 (5), 1370-1373, 1981
18411981
The cytoprotective protein C pathway
LO Mosnier, BV Zlokovic, JH Griffin
Blood 109 (8), 3161-3172, 2007
9122007
Endothelial and antithrombotic actions of HDL
C Mineo, H Deguchi, JH Griffin, PW Shaul
Circulation research 98 (11), 1352-1364, 2006
8042006
Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology
TM Hackeng, JH Griffin, PE Dawson
Proceedings of the National Academy of Sciences 96 (18), 10068-10073, 1999
7991999
Plasma protein S deficiency in familial thrombotic disease
HP Schwarz, M Fischer, P Hopmeier, MA Batard, JH Griffin
Blood 64 (6), 1297-1300, 1984
7501984
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng, D Liu, JH Griffin, JA Fernández, F Castellino, ED Rosen, ...
Nature medicine 9 (3), 338-342, 2003
7292003
Anticoagulant protein C pathway defective in majority of thrombophilic patients
JH Griffin, B Evatt, C Wideman, JA Fernandez
Blood 82 (7), 1989-1993, 1993
6871993
Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme
RA Marlar, AJ Kleiss, JH Griffin
Blood 59 (5), 1067-1072, 1982
5721982
Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial
Apex AMI Investigators
Jama 297 (1), 43-51, 2007
5232007
Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant
HE Branson, R Marble, J Katz, JH Griffin
The Lancet 322 (8360), 1165-1168, 1983
4621983
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V
CA Fulcher, JE Gardiner, JH Griffin, TS Zimmerman
Blood 63 (2), 486-489, 1984
4481984
Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.
BN Bouma, JH Griffin
Journal of Biological Chemistry 252 (18), 6432-6437, 1977
4221977
Activated protein C resistance caused by Arg506Gln mutation in factor Va
JS Greengard, X Sun, X Xu, JA Fernandez, JH Griffin, B Evatt
The Lancet 343 (8909), 1361-1362, 1994
4211994
Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII)
JH Griffin
Proceedings of the National Academy of Sciences 75 (4), 1998-2002, 1978
4061978
Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
JH Griffin, CG Cochrane
Proceedings of the National Academy of Sciences 73 (8), 2554-2558, 1976
4031976
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
G Tans, J Rosing, MC Thomassen, MJ Heeb, RF Zwaal, JH Griffin
3921991
Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C
EJ Kerschen, JA Fernandez, BC Cooley, XV Yang, R Sood, LO Mosnier, ...
The Journal of experimental medicine 204 (10), 2439-2448, 2007
3612007
The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis
CL Gladson, I Scharrer, V Hach, KH Beck, JH Griffin
Thrombosis and haemostasis 59 (01), 018-022, 1988
3441988
Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.
Y Sakata, S Curriden, D Lawrence, JH Griffin, DJ Loskutoff
Proceedings of the National Academy of Sciences 82 (4), 1121-1125, 1985
3291985
High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C
JH Griffin, K Kojima, CL Banka, LK Curtiss, JA Fernández
The Journal of clinical investigation 103 (2), 219-227, 1999
3221999
系统目前无法执行此操作,请稍后再试。
文章 1–20